Fig. 1
From: The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
DMAMCL treatment induces cell death in RMS cells in vitro. a Rhabdomyosarcoma(RMS) cell lines and control NIH3T3 cells were treated with different concentrations of DMAMCL for 72 h. Cell survival was evaluated by MTS. Each data point represents the mean, SD of triplicate wells. b Cell confluency(%) was calculated using Incucyte Zoom software based on phase-contrast images of RD, RH18, RH28, RH30 and RH41 cells from 0 h to 72 h at different concentration of DMAMCL. Each data point represents triplicate wells. c Cell confluency(%) was calculated using Incucyte Zoom software based on phase-contrast images of RD, RH18, RH28, RH30 and RH41 cells at 72 h. Each data point represents triplicate wells